DG
22
6
NSC
60
3
PCG
80
-5
PYPL
56
-4
AAL
65
9
L
55
3
NI
63
-2
AVY
68
4
LRCX
56
7
PSX
42
2
FLR
56
4
ROK
52
6
AMG
38
2
SHW
73
2
AA
63
6
PVH
54
5
KSS
54
3
COP
40
-7
HIG
68
-2
XOM
42
-3
DG
22
6
NSC
60
3
PCG
80
-5
PYPL
56
-4
AAL
65
9
L
55
3
NI
63
-2
AVY
68
4
LRCX
56
7
PSX
42
2
FLR
56
4
ROK
52
6
AMG
38
2
SHW
73
2
AA
63
6
PVH
54
5
KSS
54
3
COP
40
-7
HIG
68
-2
XOM
42
-3
Financhill
Back

Intellia Therapeutics Vs. Triumph Financial Industry Stock Comparison

Sell
16

NTLA
Intellia Therapeutics

Last Price:
21.02
Seasonality Move:
8.84%
Sell
46

TFIN
Triumph Financial

Last Price:
78.51
Seasonality Move:
12.89%
Sell
16
Intellia Therapeutics (NTLA) is a Sell

Is Intellia Therapeutics a Buy, Sell or Hold?

  • The current Intellia Therapeutics [NTLA] share price is $20.57. The Score for NTLA is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • NTLA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
46
Triumph Financial (TFIN) is a Sell

Is Triumph Financial a Buy, Sell or Hold?

  • The current Triumph Financial [TFIN] share price is $77.20. The Score for TFIN is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • TFIN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NTLA Stock Price Chart

What is Intellia Therapeutics's stock price today?

  • The Intellia Therapeutics share price today is $20.57
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTLA is experiencing slight selling pressure.

TFIN Stock Price Chart

What is Triumph Financial's stock price today?

  • The Triumph Financial share price today is $77.20
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TFIN is experiencing selling pressure, which indicates risk of future bearish movement.

NTLA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.39 Sell
Relative Strength Index (14 RSI): 40.96 Sell
Chaikin Money Flow: -540966 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.58 - 22.86) Sell
Bollinger Bands (100): (21.68 - 25.4) Sell

TFIN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.91 Sell
Relative Strength Index (14 RSI): 38 Sell
Chaikin Money Flow: -88106 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (79.12 - 83.7) Sell
Bollinger Bands (100): (74.95 - 85.81) Sell

NTLA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.76 Sell
20-day SMA: 21.37 Sell
50-day SMA: 22.88 Sell
200-day SMA: 25.29 Sell
8-day EMA: 21.31 Sell
20-day EMA: 21.63 Sell
50-day EMA: 22.44 Sell
200-day EMA: 25.82 Sell

TFIN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 80.91 Sell
20-day SMA: 80.79 Sell
50-day SMA: 83.23 Sell
200-day SMA: 77.84 Sell
8-day EMA: 79.9 Sell
20-day EMA: 80.94 Sell
50-day EMA: 81.64 Sell
200-day EMA: 77.3 Sell

Intellia Therapeutics Earnings Growth & NTLA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.07 per share, a decrease this year of $0.03 per share, and a decrease next year of $0.19 per share.

Triumph Financial Earnings Growth & TFIN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.17 per share, an increase next quarter of $0.37 per share, a decrease this year of $0.90 per share, and an increase next year of $1.31 per share.

Intellia Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Triumph Financial Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):